|
1
|
Rocha AK, de Lima E, Amaral FG, Peres R,
Cipolla-Neto J and Amado D: Pilocarpine-induced epilepsy alters the
expression and daily variation of the nuclear receptor RORα in the
hippocampus of rats. Epilepsy Behav. 55:38–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muldoon SF, Villette V, Tressard T,
Malvache A, Reichinnek S, Bartolomei F and Cossart R: GABAergic
inhibition shapes interictal dynamics in awake epileptic mice.
Brain. 138:2875–2890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsamis KI, Mytilinaios DG, Njau SN and
Baloyannis SJ: Glutamate receptors in human caudate nucleus in
normal aging and Alzheimer's disease. Curr Alzheimer Res.
10:469–475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ettinger AB, LoPresti A, Yang H, Williams
B, Zhou S, Fain R and Laurenza A: Psychiatric and behavioral
adverse events in randomized clinical studies of the noncompetitive
AMPA receptor antagonist perampanel. Epilepsia. 56:1252–1263. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harlow DE, Saul KE, Komuro H and Macklin
WB: Myelin proteolipid protein complexes with αv integrin and AMPA
receptors in vivo and regulates AMPA-dependent oligodendrocyte
progenitor cell migration through the modulation of cell-surface
GluR2 expression. J Neurosci. 35:12018–12032. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedman LK, Velísková J, Kaur J, Magrys
BW and Liu H: GluR2(B) knockdown accelerates CA3 injury after
kainate seizures. J Neuropathol Exp Neurol. 62:733–750. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tatemoto K, Carlquist M and Mutt V:
Neuropeptide Y-a novel brain peptide with structural similarities
to peptide YY and pancreatic polypeptide. Nature. 296:659–660.
1982. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Woldbye DP and Kokaia M: Neuropeptide Y
and seizures: Effects of exogenously applied ligands.
Neuropeptides. 38:253–260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malva JO, Xapelli S, Baptista S, Valero J,
Agasse F, Ferreira R and Silva AP: Multifaces of neuropeptide Y in
the brain-neuroprotection, neurogenesis and neuroinflammation.
Neuropeptides. 46:299–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vezzani A and Sperk G: Overexpression of
NPY and Y2 receptors in epileptic brain tissue: An endogenous
neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides.
38:245–252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang S, Zhou W, Zhang Y, Yan C and Zhao Y:
Effects of Liuwei Dihuang decoction on ion channels and synaptic
transmission in cultured hippocampal neuron of rat. J
Ethnopharmacol. 106:166–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atalay B, Caner H, Can A and Cekinmez M:
Attenuation of microtubule associated protein-2 degradation after
mild head injury by mexiletine and calpain-2 inhibitor. Br J
Neurosurg. 21:281–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
DeLorenzo RJ, Sombati S and Coulter DA:
Effects of topiramate on sustained repetitive firing and
spontaneous recurrent seizure discharges in cultured hippocampal
neurons. Epilepsia. 41:(Suppl 1). S40–S44. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rozov A, Sprengel R and Seeburg PH:
GluA2-lacking AMPA receptors in hippocampal CA1 cell synapses:
Evidence from gene-targeted mice. Front Mol Neurosci. 5:222012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rozov A, Zivkovic AR and Schwarz MK:
Homer1 gene products orchestrate Ca(2+)-permeable AMPA
receptor distribution and LTP expression. Front Synaptic Neurosci.
4:42012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Curtis KM, Gomez LA, Rios C, Garbayo E,
Raval AP, Perez-Pinzon MA and Schiller PC: EF1alpha and RPL13a
represent normalization genes suitable for RT-qPCR analysis of bone
marrow derived mesenchymal stem cells. BMC Mol Biol. 11:612010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dudek FE and Rogawski MA: The epileptic
neuron redux. Epilepsy Curr. 2:151–152. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bernard C, Anderson A, Becker A, Poolos
NP, Beck H and Johnston D: Acquired dendritic channelopathy in
temporal lobe epilepsy. Science. 305:532–535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kato K, Sekino Y, Takahashi H, Yasuda H
and Shirao T: Increase in AMPA receptor-mediated miniature EPSC
amplitude after chronic NMDA receptor blockade in cultured
hippocampal neurons. Neurosci Lett. 418:4–8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Solger J, Heinemann U and Behr J:
Electrical and chemical long-term depression do not attenuate
low-Mg2+-induced epileptiform activity in the entorhinal cortex.
Epilepsia. 46:509–516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Jiang L, Chen H and Zhang X:
Expression of AMPA receptor subunits in hippocampus after status
convulsion. Childs Nerv Syst. 28:911–918. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma YX, Yin JB, Fan XT, Xu HW, An N, Wan
ZB, Li ZF, Liu GL, Zhang YH and Yang Hui: Establishment of kainic
acid induced temporal lobe epilepsy in rat and study of its
neurogenesis. Acta Academiae Medicinae Militaris Tertiae.
29:872–875. 2007.
|
|
23
|
Sombati S and Delorenzo RJ: Recurrent
spontaneous seizure activity in hippocampal neuronal networks in
culture. J Neurophysiol. 73:1706–1711. 1995.PubMed/NCBI
|
|
24
|
Furtinger S, Pirker S, Czech T,
Baumgartner C, Ransmayr G and Sperk G: Plasticity of Y1 and Y2
receptors and neuropeptide Y fibers in patients with temporal lobe
epilepsy. J Neurosci. 21:5804–5812. 2001.PubMed/NCBI
|
|
25
|
Sørensen G and Woldbye DP: Mice lacking
neuropeptide Y show increased sensitivity to cocaine. Synapse.
66:840–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto BK and Raudensky J: The role of
oxidative stress, metabolic compromise, and inflammation in
neuronal injury produced by amphetamine-related drugs of abuse. J
Neuroimmune Pharmacol. 3:203–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cadet JL and Krasnova IN: Molecular bases
of methamphetamine-induced neurodegeneration. Int Rev Neurobiol.
88:101–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nunes AF, Montero M, Franquinho F, Santos
SD, Malva J, Zimmer J and Sousa MM: Transthyretin knockout mice
display decreased susceptibility to AMPA-induced neurodegeneration.
Neurochem Int. 55:454–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoy KC, Huie JR and Grau JW: AMPA receptor
mediated behavioral plasticity in the isolated rat spinal cord.
Behav Brain Res. 236:319–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Blair RE, Sombati S, Churn SB and
Delorenzo RJ: Epileptogenesis causes an N-methyl-d-aspartate
receptor/Ca2+-dependent decrease in
Ca2+/calmodulin-dependent protein kinase II activity in
a hippocampal neuronal culture model of spontaneous recurrent
epileptiform discharges. Eur J Pharmacol. 588:64–71. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Blair RE, Deshpande LS, Sombati S, Elphick
MR, Martin BR and DeLorenzo RJ: Prolonged exposure to WIN55,212-2
causes downregulation of the CB1 receptor and the development of
tolerance to its anticonvulsant effects in the hippocampal neuronal
culture model of acquired epilepsy. Neuropharmacology. 57:208–218.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gardner SM, Takamiya K, Xia J, Suh JG,
Johnson R, Yu S and Huganir RL: Calcium-permeable AMPA receptor
plasticity is mediated by subunit-specific interactions with PICK1
and NSF. Neuron. 45:903–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Essin K, Nistri A and Magazanik L:
Evaluation of GluR2 subunit involvement in AMPA receptor function
of neonatal rat hypoglossal motoneurons. Eur J Neurosci.
15:1899–1906. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Palmer CL, Cotton L and Henley JM: The
molecular pharmacology and cell biology of
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Pharmacol Rev. 57:253–277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Montero M, Nielsen M, Rønn LC, Møller A,
Noraberg J and Zimmer J: Neuroprotective effects of the AMPA
antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal
slice cultures and global cerebral ischemia in gerbils. Brain Res.
1177:124–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sager C, Tapken D, Kott S and Hollmann M:
Functional modulation of AMPA receptors by transmembrane AMPA
receptor regulatory proteins. Neuroscience. 158:45–54. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Colbourne F, Grooms SY, Zukin RS, Buchan
AM and Bennett MV: Hypothermia rescues hippocampal CA1 neurons and
attenuates down-regulation of the AMPA receptor GluR2 subunit after
forebrain ischemia. Proc Natl Acad Sci USA. 100:2906–2910. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Calderone A, Jover T, Mashiko T, Noh KM,
Tanaka H, Bennett MV and Zukin RS: Late calcium EDTA rescues
hippocampal CA1 neurons from global ischemia-induced death. J
Neurosci. 24:9903–9913. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grooms SY, Opitz T, Bennett MV and Zukin
RS: Status epilepticus decreases glutamate receptor 2 mRNA and
protein expression in hippocampal pyramidal cells before neuronal
death. Proc Natl Acad Sci USA. 97:3631–3636. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sanchez RM, Koh S, Rio C, Wang C, Lamperti
ED, Sharma D, Corfas G and Jensen FE: Decreased glutamate receptor
2 expression and enhanced epileptogenesis in immature rat
hippocampus after perinatal hypoxia-induced seizures. J Neurosci.
21:8154–8163. 2001.PubMed/NCBI
|
|
41
|
Hanley JG and Henley JM: PICK1 is a
calcium-sensor for NMDA-induced AMPA receptor trafficking. EMBO J.
24:3266–3278. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Y, Venkitaramani DV, Gladding CM,
Zhang Y, Kurup P, Molnar E, Collingridge GL and Lombroso PJ: The
tyrosine phosphatase STEP mediates AMPA receptor endocytosis after
metabotropic glutamate receptor stimulation. J Neurosci.
28:10561–10566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dev KK, Nakanishi S and Henley JM: The PDZ
domain of PICK1 differentially accepts protein kinase C-alpha and
GluR2 as interacting ligands. J Biol Chem. 279:41393–41397. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Alvaro AR, Martins J, Costa AC, Fernandes
E, Carvalho F, Ambrósio AF and Cavadas C: Neuropeptide Y protects
retinal neural cells against cell death induced by ecstasy.
Neuroscience. 152:97–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Baptista S, Bento AR, Gonçalves J,
Bernardino L, Summavielle T, Lobo A, Fontes-Ribeiro C, Malva JO,
Agasse F and Silva AP: Neuropeptide Y promotes neurogenesis and
protection against methamphetamine-induced toxicity in mouse
dentate gyrus-derived neurosphere cultures. Neuropharmacology.
62:2413–2423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jinde S, Masui A, Morinobu S, Noda A and
Kato N: Differential changes in messenger RNA expressions and
binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the
hippocampus of an epileptic mutant rat: Noda epileptic rat.
Neuroscience. 115:1035–1045. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Woldbye DP, Nanobashvili A, Sørensen AT,
Husum H, Bolwig TG, Sørensen G, Ernfors P and Kokaia M:
Differential suppression of seizures via Y2 and Y5 neuropeptide Y
receptors. Neurobiol Dis. 20:760–772. 2005. View Article : Google Scholar : PubMed/NCBI
|
